Conference on Retrovirus and Opportunistic Infections (CROI 2024), Denver, Colorado, USA, 3-6 March 2024.

Poster presentations:

  • Temporal Trends of Cardiovascular Disease Incidence in People with HIV from 2001-2021  presented by Nadine Jaschinski on behalf of the RESPOND Study Group.POSTER  
  • Increased Cancer Risk With Low CD4 Counts Persists Despite Over 2 Years of Virological Suppression   presented by Jennifer Hoy on behalf of the RESPOND Study Group.POSTER

The 25th International AIDS conference (IAS) 22 - 26 July  2024.

Accepted for oral presentation:

  • Detailed modeling of viremia exposure does not independently predict cardiovascular diseases in people with HIV, will be presented by Olof Elvstam on behalf of the RESPOND Study Group

Australasian HIV & AIDS conference (ASHM), Sydney, Australia, 16-18 September 2024.

Accepted for oral presentation:

  • Risk of cancer in people with HIV with poor immune recovery despite sustained virological suppression for more than two years on effective antiretroviral treatment, will be​ presented by Win Min Han on behalf of the RESPOND Study Group